Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
10/19/2006 | WO2006108709A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
10/19/2006 | WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
10/19/2006 | WO2006108699A1 Indazoles as glucocorticoid receptor ligands |
10/19/2006 | WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors |
10/19/2006 | WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
10/19/2006 | WO2006108487A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer |
10/19/2006 | WO2006069395A3 Synthetic process for the preparation of biocyclic compounds |
10/19/2006 | WO2006050964A3 Indinavir derivatives useful in immunoassay |
10/19/2006 | WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use |
10/19/2006 | WO2006014618A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
10/19/2006 | WO2005014542A3 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament against cancer, and method for the production thereof |
10/19/2006 | US20060235223 Variolin derivatives and their use as antitumor agents |
10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
10/19/2006 | US20060235055 Therapeutic agents useful for treating pain |
10/19/2006 | US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
10/19/2006 | US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
10/19/2006 | US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same |
10/19/2006 | US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors |
10/19/2006 | US20060235019 Substituted quinazolinone compounds |
10/19/2006 | US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
10/19/2006 | US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators |
10/19/2006 | US20060235014 Inhibitors of p38 |
10/19/2006 | US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
10/19/2006 | US20060234984 Mitotic kinesin inhibitors |
10/19/2006 | US20060230554 Cyanin-type compounds having an alkynyl linker arm |
10/19/2006 | DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds |
10/19/2006 | DE102005061720B3 Preparing optically active omeprazole enantiomers, useful to treat stomach diseases, comprises oxidizing prochiral sulfide compound with oxidizing agent in presence of titanium complex catalyst and reacting the catalyst with chiral diols |
10/19/2006 | DE102005016634A1 Neuartige Aza-Hetercyclen als Kinase-Inhibitoren Novel aza-heterocycles as kinase inhibitors |
10/19/2006 | CA2604895A1 (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer |
10/19/2006 | CA2604836A1 Pyrimidine derivatives and their use in the treatment of cancer |
10/19/2006 | CA2604773A1 Npy antagonists, preparation and use |
10/19/2006 | CA2604516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
10/19/2006 | CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
10/19/2006 | CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors |
10/19/2006 | CA2603701A1 1,4-substituted piperazine derivative |
10/19/2006 | CA2603320A1 Pyridylmethylsulfone derivative |
10/19/2006 | CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
10/19/2006 | CA2598207A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
10/18/2006 | EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors |
10/18/2006 | EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
10/18/2006 | EP1712242A1 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
10/18/2006 | EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
10/18/2006 | EP1711825A2 Conjugated small molecules |
10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
10/18/2006 | EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
10/18/2006 | EP1711491A1 Heterocyclic derivatives as gpcr receptor agonists |
10/18/2006 | EP1711485A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
10/18/2006 | EP1711484A1 Synthesis of cyanoimino-benzoimidazoles |
10/18/2006 | EP1711474A1 5-phenypyridines and their use as microbicides |
10/18/2006 | EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect |
10/18/2006 | EP1711181A1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
10/18/2006 | EP1711179A2 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole |
10/18/2006 | EP1711175A1 Diurea derivatives |
10/18/2006 | EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
10/18/2006 | EP1345932B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
10/18/2006 | EP1070713B1 Quinolonecarboxylic acid derivatives or salts thereof |
10/18/2006 | EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
10/18/2006 | CN1849316A 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative |
10/18/2006 | CN1849315A Novel amides useful for treating pain |
10/18/2006 | CN1849308A Thiophenylaminoimidazolines |
10/18/2006 | CN1849307A Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
10/18/2006 | CN1849126A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
10/18/2006 | CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents |
10/18/2006 | CN1849121A Piperazine derivatives as bradyknin antagonist |
10/18/2006 | CN1849120A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
10/18/2006 | CN1847241A Synthesis process of 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolyl-2-imine |
10/18/2006 | CN1847240A Prazole derivative and its salt and use |
10/18/2006 | CN1847231A Process of preparing aromatic ring substituted ixooxazoline compound |
10/18/2006 | CN1846697A New use of angiotensin ii antagonists |
10/18/2006 | CN1280287C Process for producing crystal |
10/18/2006 | CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring |
10/18/2006 | CN1280276C 9-aminoacridine derivatives and process for the preparation thereof |
10/18/2006 | CN1280275C Pyridione derivatives for tretment of atherosclerosis |
10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
10/17/2006 | US7122680 3-Substituted oxindole β3 agonsists |
10/17/2006 | US7122677 NK1 antagonists |
10/17/2006 | US7122675 Gamma secretase inhibitors |
10/17/2006 | US7122674 Process for preparing high-purity hydroxyindolylglyoxylamides |
10/17/2006 | US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
10/17/2006 | US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR) |
10/17/2006 | US7122562 Amine oxidase inhibitor; use in treatment of Alzheimer's disease and senile dementia |
10/17/2006 | US7122560 Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
10/17/2006 | US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
10/17/2006 | US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
10/17/2006 | US7122556 Phenylalanine enamide derivatives |
10/17/2006 | US7122551 Metalloproteinase inhibitor compounds |
10/17/2006 | US7122550 Protein kinase inhibitors |
10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
10/17/2006 | US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
10/17/2006 | US7121707 Illuminated electrical cords and outlets |
10/17/2006 | CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p |